Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Aurobindo Pharma Limited partners with global pharma company for product development

Nov 25, 2024•over 1 year ago

Contract Type

partnership

United StatesManufacturingBiotechnologyPharmaceutical

Description

Aurobindo Pharma Limited's stock has jumped by 2.6 percent after the company collaborated with a global pharma major for the development and commercialization of products. The collaboration and licensing agreement involves an upfront payment of $25 million and is expected to last between three to five years.

Company Information

Company

Aurobindo

Location

United States

About

Aurobindo is a leading pharmaceutical manufacturing company. They focus on developing high-quality generic and branded products. The company operates globally, serving a diverse range of therapeutic segments. Aurobindo aims to improve health outcomes through accessible medicines.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Aurobindo's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.